CandlesenseCandlesense
News/Companies/PRVA

PRVA News

Privia Health Reports Second Quarter 2025 Financial Results

PRVA

Strong Performance Across Key Metrics; Guidance Raised to Above High End of Range for Practice Collections, GAAP Revenue, Platform Contribution, Adj EBITDA

August 7, 2025Earnings
Read more →

JP Morgan Maintains Overweight on Privia Health Gr, Raises Price Target to $32

PRVA

May 28, 2025
Read more →

Barclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $24

PRVA

May 27, 2025
Read more →

Privia Health Gr Affirms FY2025 Sales Guidance of $1.80B-$1.90B vs $3.22B Est

PRVA

May 8, 2025
Read more →

Privia Health Gr Q1 Adj. EPS $0.22 Beats $0.05 Estimate, Sales $480.10M Miss $777.08M Estimate

PRVA

May 8, 2025
Read more →

JMP Securities Reiterates Market Outperform on Privia Health Gr, Maintains $29 Price Target

PRVA

April 28, 2025
Read more →

Investigating Privia Health Gr's Standing In Health Care Providers & Services Industry Compared To Competitors

PRVA

April 16, 2025
Read more →

Assessing Privia Health Gr: Insights From 10 Financial Analysts

PRVA

April 15, 2025
Read more →

Baird Maintains Outperform on Privia Health Gr, Raises Price Target to $26

PRVA

April 15, 2025
Read more →

Barclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $23

PRVA

April 10, 2025
Read more →

Truist Securities Maintains Buy on Privia Health Gr, Lowers Price Target to $28

PRVA

April 10, 2025
Read more →

Needham Reiterates Buy on Privia Health Gr, Maintains $30 Price Target

PRVA

April 10, 2025
Read more →

Privia Health Group Signs Definitive Agreement To Enter Arizona In Partnership With Integrated Medical Services. Group Manages Over 28,000 Attributed Lives

PRVA

April 9, 2025
Read more →

Breaking Down Privia Health Gr: 10 Analysts Share Their Views

PRVA

March 21, 2025
Read more →

Needham Reiterates Buy on Privia Health Gr, Maintains $30 Price Target

PRVA

March 21, 2025
Read more →

Citizens Capital Markets Maintains Market Outperform on Privia Health Gr, Raises Price Target to $29

PRVA

February 28, 2025
Read more →

Canaccord Genuity Maintains Buy on Privia Health Gr, Raises Price Target to $30

PRVA

February 28, 2025
Read more →

Piper Sandler Maintains Overweight on Privia Health Gr, Raises Price Target to $40

PRVA

February 28, 2025
Read more →

Needham Maintains Buy on Privia Health Gr, Raises Price Target to $30

PRVA

February 28, 2025
Read more →

CORRECTION: Privia Health Gr Q4 2024 GAAP EPS $0.21 Up From $0.15 YoY, Sales $460.90M Up From $440.83M YoY

PRVA

February 27, 2025
Read more →

Privia Health Gr Sees FY2025 Sales $1.800B-$1.900B vs $3.23B Est

PRVA

February 27, 2025
Read more →

Privia Health Gr Q4 Adj $0.21 Beats $0.05 Estimate, Sales $460.90M Miss $719.97M Estimate

PRVA

February 27, 2025
Read more →

What Analysts Are Saying About Privia Health Gr Stock

PRVA

February 14, 2025
Read more →

JMP Securities Maintains Market Outperform on Privia Health Gr, Maintains $26 Price Target

PRVA

February 14, 2025
Read more →

Needham Reiterates Buy on Privia Health Gr, Maintains $25 Price Target

PRVA

January 15, 2025
Read more →

Needham Initiates Coverage On Privia Health Gr with Buy Rating, Announces Price Target of $25

PRVA

January 10, 2025
Read more →

Barclays Maintains Equal-Weight on Privia Health Gr, Lowers Price Target to $19

PRVA

May 20, 2024
Read more →

B of A Securities Initiates Coverage On Privia Health Group with Buy Rating, Announces Price Target of $27

PRVA

May 3, 2022
Read more →

Expert Ratings for Privia Health Group

PRVA

Analysts have provided the following ratings for Privia Health Group (NASDAQ:PRVA) within the last quarter:

April 28, 2022
Read more →

BTIG Initiates Coverage On Privia Health Group with Buy Rating, Announces Price Target of $35

PRVA

April 28, 2022
Read more →